Chemical activators of PQLC3 utilize a variety of intracellular signaling pathways to modulate the activity of this protein. Phorbol 12-myristate 13-acetate (PMA), for example, is known to activate protein kinase C (PKC), which is part of signaling cascades that involve PQLC3. Activation of PKC leads to phosphorylation events downstream that can result in the activation of PQLC3. Similarly, Forskolin raises intracellular cAMP levels, thereby activating PKA, which can also phosphorylate proteins within PQLC3's pathways, leading to its activation. Ionomycin functions by increasing intracellular calcium levels, which then can activate calmodulin-dependent protein kinases (CaMK). These kinases have the capability to phosphorylate and activate PQLC3. Okadaic Acid, by inhibiting protein phosphatases PP1 and PP2A, prevents the dephosphorylation, thus keeping proteins within PQLC3's pathway in an active phosphorylated state.
Other activators include Epidermal Growth Factor (EGF), which triggers the MAPK/ERK pathway, leading to phosphorylation and subsequent activation of proteins in pathways that include PQLC3. Thapsigargin disrupts calcium homeostasis, leading to the activation of calcium-dependent kinases that can activate PQLC3. Anisomycin stimulates the JNK pathway, involving stress-activated protein kinases that can activate PQLC3. Tumor Necrosis Factor-alpha (TNF-α) activates the NF-κB pathway, which includes kinases that phosphorylate and activate proteins within PQLC3's pathway. Moreover, arachidonic acid metabolism produces eicosanoids that can activate kinases in PQLC3's signaling pathways. Phosphatidic Acid is involved in the activation of mTOR signaling, which is known to phosphorylate proteins within signaling pathways, including those involving PQLC3. Calcium Ionophore A23187 raises intracellular calcium, which activates protein kinases that can phosphorylate and activate PQLC3. Lastly, Calyculin A inhibits protein phosphatases, which can lead to the sustained activation of PQLC3 within its signaling pathways. Each of these chemicals, through their various mechanisms, can contribute to the state of activation of PQLC3 by influencing the phosphorylation status of the protein and its associated pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is part of signaling pathways that PQLC3 is involved in. PKC activation leads to downstream effects that result in the activation of PQLC3. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent protein kinases (CaMK). These kinases can phosphorylate and thereby activate proteins within the pathways that include PQLC3. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic Acid inhibits protein phosphatase PP1 and PP2A, preventing dephosphorylation of proteins in pathways involving PQLC3. This maintains proteins in a phosphorylated state, which is associated with activation, thereby facilitating the activation of PQLC3. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis, leading to activation of calcium-dependent kinases. These kinases can then activate PQLC3 through phosphorylation within its signaling pathways. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin activates the JNK pathway, which includes stress-activated protein kinases that can phosphorylate and thereby activate proteins in the pathway that involves PQLC3. | ||||||
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
Arachidonic Acid metabolism results in the production of eicosanoids, which in turn activate kinases within signaling pathways that PQLC3 is part of. The activation of these kinases can lead to the activation of PQLC3. | ||||||
Phosphatidic Acid, Dipalmitoyl | 169051-60-9 | sc-201057 sc-201057B sc-201057A | 100 mg 250 mg 500 mg | $106.00 $244.00 $417.00 | ||
Phosphatidic Acid is involved in activation of mTOR signaling, which is known to phosphorylate proteins within signaling pathways. Activation of mTOR can lead to the activation of PQLC3 as part of these pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Calcium Ionophore A23187 increases intracellular calcium, which can activate calcium-dependent protein kinases. These kinases can phosphorylate and activate PQLC3 within its signaling pathways. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Calyculin A inhibits protein phosphatases, maintaining proteins in their phosphorylated state within pathways that PQLC3 is a part of. This could lead to sustained activation of PQLC3 through its pathway. | ||||||